Skip to content

Bempedoic Acid

Bempedoic acid is an ATP-citrate lyase inhibitor that reduces cholesterol synthesis upstream of HMG-CoA reductase in the liver.

Nexletol

Primary Hypercholesterolaemia, Mixed Dyslipidaemia

180mg

Utilised to target hypercholesterolaemia to mitigate cardiovascular risk.

From$1.93/ tabletView

Key points

  • Bempedoic acid is activated mainly in the liver.
  • Its LDL-lowering action comes from inhibiting ATP-citrate lyase.

Nexletol provides the direct brand identity for bempedoic acid in cholesterol management. Increased uric acid, gout and tendon injury are distinctive safety topics in official information. The medicine class and hepatic activation supply more useful taxonomy context than repeating the tablet strength.

Further reading